⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10386917 | 0.74 | — | — | |
| SCHEMBL1444125 | 0.69 | — | — | |
| SCHEMBL5888401 | 0.69 | — | — | |
| SCHEMBL16979015 | 0.67 | — | — | |
| SCHEMBL13028747 | 0.65 | — | — | |
| SCHEMBL15120003 | 0.65 | — | — | |
| SCHEMBL7569194 | 0.65 | — | — | |
| SCHEMBL3145376 | 0.65 | — | — | |
| SCHEMBL9179909 | 0.65 | USP2 (0.35) | — | |
| SCHEMBL8832716 | 0.64 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2018141854-A1 | PIPERAZINE DERIVATIVES FOR INFLUENZA VIRUS INHIBITION | JANSSEN VACCINES & PREVENTION B.V. (NL) | 2018-08-09 | — | — | WO | claimed |
| CN-106966994-A | A kind of triazole of N sulfonyls 1,2,3 of new 4 allyl acetic acid ester group substitution and preparation method thereof | 大连理工大学 | 2017-07-21 | — | — | CN | claimed |
| CN-106565535-A | Preparation method for 2-diazonium-1-alkyl ketone compound | 山西师范大学 | 2017-04-19 | — | — | CN | claimed |
| CN-103755725-B | 7 β-phenylacetylamino-3-is without the preparation method of-3-cephem-4-diphenylmethyl carboxylate | JIANG University OF TECHNOLOGY (CN) | 2016-05-18 | — | — | CN | claimed |
| US-20150246931-A1 | PROCESS FOR THE PREPARATION OF TAZOBACTAM | HOSPIRA, INC. (US) | 2015-09-03 | — | — | US | claimed |
| EP-2892903-A1 | PROCESS FOR THE PREPARATION OF TAZOBACTAM | Orchid Chemicals and Pharmaceuticals Ltd (IN) | 2015-07-15 | — | — | EP | claimed |
| WO-2014037893-A1 | PROCESS FOR THE PREPARATION OF TAZOBACTAM | ORCHID CHEMICALS & PHARMACEUTICALS LTD (IN) | 2014-03-13 | — | — | WO | claimed |
| CN-103553987-A | Methyl sulfone chloride acyl azide preparation method | ANHUI LANGXI LIANKE IND CO LTD | 2014-02-05 | — | — | CN | claimed |
| CN-101891666-B | Preparation method of intermediate of beta methylcarbapenem antibiotics | SHENZHEN HAIBIN PHARMACEUTICAL | 2012-09-26 | — | — | CN | claimed |
| CN-102137865-A | Process for the preparation of carbapenem compounds | RANBAXY LAB LTD | 2011-07-27 | — | — | CN | claimed |
| CN-101891666-A | Preparation method of intermediate of beta methylcarbapenem antibiotics | SHENZHEN HAIBIN PHARMACEUTICAL | 2010-11-24 | — | — | CN | claimed |
| CN-115458808-A | Method for producing lithium fluorosulfonate, nonaqueous electrolytic solution, and nonaqueous electrolyte secondary battery | 三菱化学株式会社 | 2022-12-09 | — | — | CN | disclosed |
| CN-112469279-B | Fungicides for the prevention and control of fungal pathogens | 洛桑大学 | 2022-05-31 | — | — | CN | disclosed |
| CN-113387375-A | Method for producing lithium fluorosulfonate, nonaqueous electrolyte solution, and nonaqueous electrolyte secondary battery | 三菱化学株式会社 | 2021-09-14 | — | — | CN | disclosed |
| US-11040963-B2 | Piperazine derivatives for influenza virus inhibitions | JANSSEN VACCINES & PREVENTION B.V. (NL) | 2021-06-22 | — | — | US | disclosed |
| CN-1333769-A | Thiourea inhibitors of herps viruses | AMERICAN HOME PROD (US) | 2002-01-30 | — | — | CN | disclosed |
| CN-1333750-A | Acetamide and substituted acetamide-containing thiourea inhibitors of herpes viruses | AMERICAN HOME PROD (US) | 2002-01-30 | — | — | CN | disclosed |
| CN-1332725-A | Thiourea inhibitors of herpes viruses | AMERICAN HOME PROD (US) | 2002-01-23 | — | — | CN | disclosed |
| CN-1067429-A | The 4-substituted alkyl carbapenem antibiotics | BRISTOL MYERS SQUIBB CO (US) | 1992-12-30 | — | — | CN | disclosed |
| CN-87107548-A | Strengthen the compositions of transdermal flux | — | 1988-05-11 | — | — | CN | disclosed |